Exchange: NASDAQ·Updated 07:30 PM EST

HSIC News

News
all
press releases
Compared to Estimates, Henry Schein (HSIC) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Henry Schein (HSIC) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks
Compared to Estimates, Henry Schein (HSIC) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Henry Schein (HSIC) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks
More News
HSIC Q3 Earnings Beat, Revenues Match, '26 EPS View Up, Stock Down
Henry Schein beats Q3 earnings estimates, matches revenue forecasts and raises its 2026 EPS outlook, yet shares slip despite strong dental and technology sales.
Zacks
Henry Schein (HSIC) Tops Q3 Earnings Estimates
Henry Schein (HSIC) delivered earnings and revenue surprises of +16.42% and 0.00%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Henry Schein Reports Strong 2026 Third Quarter and Raises FY2026 Guidance
Henry Schein, Inc. (Nasdaq: HSIC), the worlds largest provider of healthcare solutions to office-based dental and medical practitioners, today reported financial results for the third quarter ended September 26, 2026. The Company reported $3.5 billion in sales with total growth of 4.0%, and 3.1...
Business Wire
Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
Earnings Preview: Staar Surgical (STAA) Q3 Earnings Expected to Decline
Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Analysts Estimate Henry Schein (HSIC) to Report a Decline in Earnings: What to Look Out for
Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks
Henry Schein to Report Q3 Earnings: Here's What You Should Know
HSIC gears up for Q3 earnings with revenue growth expected across its three segments, fueled by dental products, specialty demand and cloud-based technology.
Zacks
Henry Schein to Webcast Third Quarter 2026 Conference Call on Tuesday, November 3, 2026, at 8:00 a.m. ET
Henry Schein, Inc. (Nasdaq: HSIC), the worlds largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its third quarter 2026 financial results before the stock market opens on Tuesday, November 3, 2026, and will provide a live...
Business Wire
Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks

Advertisement|Remove ads.